FDA extends tie-up with CN Bio to test ‘lung-on-a-chip’ tech

The FDA has extended a collaboration with the UK firm CN Bio to investigate a “lung-on-a-chip” model to investigate inhaled drugs.

In a statement the firm said the move follows the success of a pilot project to assess the performance of the technology.